Rani Therapeutics Holdings (RANI) Total Debt (2020 - 2025)
Rani Therapeutics Holdings' Total Debt history spans 6 years, with the latest figure at $13.5 million for Q3 2025.
- On a quarterly basis, Total Debt fell 52.17% to $13.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $13.5 million, a 52.17% decrease, with the full-year FY2024 number at $24.6 million, down 16.23% from a year prior.
- Total Debt came in at $13.5 million for Q3 2025, down from $17.2 million in the prior quarter.
- The five-year high for Total Debt was $29.5 million in Q2 2024, with the low at $30000.0 in Q2 2022.
- Historically, Total Debt has averaged $19.3 million across 5 years, with a median of $24.6 million in 2024.
- Biggest five-year swings in Total Debt: plummeted 99.23% in 2022 and later surged 97450.0% in 2023.
- Year by year, Total Debt stood at $126000.0 in 2021, then soared by 23034.13% to $29.1 million in 2022, then rose by 0.8% to $29.4 million in 2023, then decreased by 16.23% to $24.6 million in 2024, then crashed by 45.0% to $13.5 million in 2025.
- Business Quant data shows Total Debt for RANI at $13.5 million in Q3 2025, $17.2 million in Q2 2025, and $20.9 million in Q1 2025.